NCT03543982 is a NA clinical trial of Oral probiotic product in Vaginal Health, sponsored by UAS Labs LLC.

Who is sponsoring NCT03543982?

NCT03543982 is sponsored by UAS Labs LLC.

What drugs are being tested in NCT03543982?

Interventions in NCT03543982: Oral probiotic product.

What condition does NCT03543982 study?

NCT03543982 studies Vaginal Health.

Is NCT03543982 still recruiting?

NCT03543982 is currently completed. Last updated 8 April 2021.

Last reviewed 2021-04-08 · How we verify

NCT03543982

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Oral Probiotic Product on Vaginal Microbial Community and Parameters of Vaginal Health

Completed NA Last updated 8 April 2021

What this trial tests

NA trial testing Oral probiotic product in Vaginal Health in 37 participants. Completed in 18 March 2021.

Timeline

23 May 2018

Primary endpoint
1 October 2020

18 March 2021

Quick facts

Lead sponsor	UAS Labs LLC
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	37
Start date	23 May 2018
Primary completion	1 October 2020
Estimated completion	18 March 2021
Sites	1 location across Canada

Drugs / interventions tested

Oral probiotic product

Conditions studied

Vaginal Health — all drugs for Vaginal Health →

Sponsor

UAS Labs LLC

Who can join

Adults 18 to 50, female only, with Vaginal Health. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the study is to assess the efficacy and safety of an oral probiotic product on the vaginal microbiome and on parameters of vaginal health. Eligible subjects will utilize the investigational product as directed for a period of 28 days. The vaginal microbial community and parameters of vaginal health will be measured at baseline and after 14 and 28 days of supplementation. A follow-up post-supplementation visit will be conducted on Day 42.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effects of a 10-Strain Oral Probiotic on Parameters of Vaginal Health and Microbial Community: A Pilot Clinical Study.
Martoni CJ, Frederiksen AKS, Damholt A, Leyer G. · · 2022 · cited 11× · PMID 35082535 · DOI 10.2147/ijwh.s341046

Verify or expand the search:

Other recruiting trials for Vaginal Health

Currently open trials in the same condition.

NCT06925139 — Efficacy of Non-Ablative Radiofrequency on Vaginal and Sexual Health in Postmenopausal Women · NA · active not recruiting

Other UAS Labs LLC trials

Trials by the same sponsor.

NCT04260997 — Effect of a Probiotic, Lactobacillus Gasseri BNR17, on Body Composition and Weight Management in Overweight Adults · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03543982 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by UAS Labs LLC
Last refreshed: 8 April 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03543982.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing